Icon Bioscience, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2004-01-01
- Employees
- 51
- Market Cap
- -
Clinical Trials
5
Active:0
Completed:3
Trial Phases
2 Phases
Phase 2:3
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (60.0%)Phase 3
2 (40.0%)Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery
- First Posted Date
- 2015-09-11
- Last Posted Date
- 2018-08-21
- Lead Sponsor
- ICON Bioscience Inc
- Target Recruit Count
- 194
- Registration Number
- NCT02547623
- Locations
- 🇺🇸
Kislinger MD inc, Glendora, California, United States
🇺🇸Inland Eye Specialists, Hemet, California, United States
🇺🇸Harvard Eye Associated, Laguna Hills, California, United States
The Efficacy and Safety of IBI-10090 for the Treatment of Inflammation Associated With Cataract Surgery
- First Posted Date
- 2013-12-10
- Last Posted Date
- 2018-04-23
- Lead Sponsor
- ICON Bioscience Inc
- Target Recruit Count
- 394
- Registration Number
- NCT02006888
- Locations
- 🇺🇸
Hull Eye Center, Lancaster, California, United States
Efficacy and Safety of IBI-10090 in Ocular Surgery Patients
- First Posted Date
- 2012-05-28
- Last Posted Date
- 2014-09-22
- Lead Sponsor
- ICON Bioscience Inc
- Target Recruit Count
- 172
- Registration Number
- NCT01606735
- Locations
- 🇺🇸
Inland Eye Specialists, Hemet, California, United States
🇺🇸California Eye Professionals, Temecula, California, United States
Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients
- First Posted Date
- 2010-10-04
- Last Posted Date
- 2013-09-18
- Lead Sponsor
- ICON Bioscience Inc
- Target Recruit Count
- 42
- Registration Number
- NCT01214174
- Locations
- 🇺🇸
Drs. Fine, Hoffman, and Packer, Eugene, Oregon, United States
Efficacy and Safety Study of IBI-10090 in Patients Undergoing Cataract Surgery
Phase 2
Terminated
- Conditions
- Inflammatory Reaction Due to Ocular Lens Prosthesis
- Interventions
- First Posted Date
- 2010-01-13
- Last Posted Date
- 2018-12-04
- Lead Sponsor
- ICON Bioscience Inc
- Target Recruit Count
- 6
- Registration Number
- NCT01048593
- Locations
- 🇺🇸
Altos Eye Physicians, Los Altos, California, United States
News
No news found